Stock market announcement archive

LIFE: The European Patent Office intends to issue new Lifecare patent

November 8, 2023
Bergen, Norway, November 8th, 2023: Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that the European Patent Office (EPO) has reported its intent to grant Lifecare a new patent. Lifecare will review the examining division’s comments to the patent application and respond to the […]
Read more

LIFE: Lifecare receives regulatory approval to start LFC-SEN-002

November 7, 2023
Bergen, Norway, November 7th, 2023: Today, Lifecare AS (LIFE), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), announces that The Norwegian Food Safety Authority (NFSA) has awarded all necessary approvals to start LFC-SEN-002. Reference is made to Lifecare’s list of trigger events, as presented at the semi-annual report of […]
Read more

Lifecare – Valuation Report of the Sencell technology (CGM) for diabetes

November 1, 2023
Bergen, Norway, November 1st, 2023: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes a new valuation report of Lifecare’s CGM-technology. The report is enclosed and available on the bottom of this text. Commissioned by Lifecare, the life science technology valuation-company Xplico has […]
Read more